Skip to main content
SpringerLink
Log in

Platelet — Vessel Wall Interactions in Individuals who Smoke Cigarettes

  • Chapter
Book cover Tobacco Smoking and Atherosclerosis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 273))

Abstract

Sudden cardiac death is the most frequent cause of mortality in industrialized societies accounting for the majority of the over 325,000 smoking-related deaths each year in the United States1. The strong link between cigarette smoking and the platelet-modulated syndrome of sudden cardiac death2,3 implicates smoking as a cause of platelet activation. Consistent with this hypothesis of a direct activation of platelets is that platelet turnover appears to be accelerated in apparently healthy smokers4,5. However, an enhanced turnover of platelets may be the result of their increased clearance following membrane alterations after interaction with a damaged vasculature and conversely, thrombosis has been shown to occur in vivo without evidence of increased turnover6–8. Thus, an enhanced platelet turnover in smokers may not necessarily reflect a direct activation of platelets in vivo. In fact, ex vivo aggregation has been found to be either increased9,10, unchanged4,12–14 or significantly decreased15,16 in chronic smokers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. W. B. Kannel. Update on the role of cigarette smoking in coronary artery disease. Am. Heart J. 101:319 (1981).

    Article  PubMed  CAS  Google Scholar 

  2. M. J. Davies and A. Thomas. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310:1137 (1984).

    Article  PubMed  CAS  Google Scholar 

  3. E. Falk. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 71:699 (1985).

    Article  PubMed  CAS  Google Scholar 

  4. J. F. Mustard and E. A. Murphy. Effect of smoking on blood coagulation and platelet survival in man. Br. Med. J. 1:846 (1963).

    Article  PubMed  CAS  Google Scholar 

  5. V. Fuster, J. H. Cheseboro, R. L. Frye, and L. R. Elveback. Platelet survival and the development of coronary artery disease in the young adult: Effects of cigarette smoking, strong family history and medical therapy. Circulation 63:546 (1981).

    Article  PubMed  CAS  Google Scholar 

  6. B. L. Kinlough-Rathbone, M. A. Packam and J. F. Mustard. Vessel injury, platelet-adherence and platelet survival. Arteriosclerosis 3:529 (1983).

    Article  PubMed  CAS  Google Scholar 

  7. P. D. Winocour, M. Cattaneo, D. Somers, M. Richardson, R. L. Kinlough-Rathbone and J. F. Mustard. Platelet survival and thrombosis. Arteriosclerosis 2:458 (1982).

    Article  PubMed  CAS  Google Scholar 

  8. H. M. Graves, R. L. Kinlough-Rathbone, M. Richardson, L. Jorgensen, S. Moore and J. F. Mustard. Thrombin generation and fibrosis formation following injury to rabbit neointima: Studies of vessel wall reactivity and platelet survival. Lab. Invest. 46:605 (1982).

    Google Scholar 

  9. P. Ashby, A. M. Dalby and J. H. Millar. Smoking and platelet stickiness. Lancet 2:158 (1965).

    Article  Google Scholar 

  10. R. I. Hawkins. Smoking, platelets and thrombosis. Nature 236:450 (1972).

    Article  PubMed  CAS  Google Scholar 

  11. K. G. Schmidt and J. W. Rasmussen. Acute platelet activation-induced by smoking: in vivo and ex vivo studies in man. Throm. Haemost. 51:279 (1984).

    CAS  Google Scholar 

  12. L. E. Murchison and T. Fyfe. Effects of cigarette smoking on serumlipids, blood glucose and platelet adhesiveness. Lancet 2:182 (1966).

    Article  PubMed  CAS  Google Scholar 

  13. W. Siess, R. Lorenz, P. Roth and P. C. Weber. Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking and norepinephrine infusion. Circulation 66:41 (1982).

    Article  Google Scholar 

  14. W. R. Rogers, R. L. Bass III, D. E. Johnson, A. W. Kruski, C. A. McMahon, M. M. Montiel, G. E. Mott, R. L. Wilbur and H. C. McGill, Jr. Atherosclerosis-related responses to cigarette smoking in the baboon. Circulation 61:1188 (1980).

    PubMed  CAS  Google Scholar 

  15. A. Mansouri and C. A. Perry. Inhibition of platelet ADP and serotonin release by carbon monoxide. Experientia 40:515 (1984).

    Article  PubMed  CAS  Google Scholar 

  16. T. W. Meade, M. V. Vicekers, S. G. Thompson, Y. Styirling, A. P. Haines and G. J. Miller. Epidemiological characteristics of platelet aggregability. Br. Med. J. 290:428 (1985).

    Article  CAS  Google Scholar 

  17. B. Samuelsson. The role of prostaglandin endoperoxides and thromboxanes as bioregulators. in: “Proceedings of the Intrascience Symposium on the New Biochemistry of Prostaglandins and Thromboxanes.” N. Kharsch and J. Fried, eds., Publisher New York Academic Press, Santa Monica, CA (1977).

    Google Scholar 

  18. F. Catella and G. A. FitzGerald. Paired analysis of urinary thromboxane B2 metabolites in humans. Throm. Research 47:647 (1987).

    Article  CAS  Google Scholar 

  19. D. J. Fitzgerald, F. Catella, L. Roy and G. A. Fitzgerald. Platelet activation in unstable coronary disease. N. Engl. J. Med. 315:983 (1986).

    Article  PubMed  CAS  Google Scholar 

  20. D. J. Fitzgerald, J. Doran, E. K. Jackson and G. A. FitzGerald. Coronary vascular occlusion mediated through thromboxane A2-endoperoxide receptor activation in vivo. J. Clin. Invest. 77:496 (1986).

    Article  PubMed  CAS  Google Scholar 

  21. I. Asmussen and K. Kjeldsen. Intimal ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and nonsmoking mothers. Circ. Res. 36:579 (1975).

    PubMed  CAS  Google Scholar 

  22. H. K. Thomsen. Carbon monoxide-induced atherosclerosis in primates. Atherosclerosis 20:233 (1974).

    Article  PubMed  CAS  Google Scholar 

  23. P. Ribeiro, R. Walesby, S. Edmonson, A. V. Jadhar, I. Traynor, C. M. Oakley and G. R. Thompson. Collagen content of atherosclerotic arteries is higher in smokers than in nonsmokers. Lancet 2:107 (1983).

    Google Scholar 

  24. J. H. Reinders, H-J. M. Brinkman, J. A. van Mourik and P. G. deGroot. Cigarette smoke impairs endothelial cell prostacyclin production. Arteriosclerosis 6:15 (1986).

    Article  PubMed  CAS  Google Scholar 

  25. T. Sonnenfeld and Å. Wennmalm. Inhibition by nicotine of the formation of prostacyclin-like activity in rabbit and human vascular tissue. Br. J. Pharmacol. 71:609 (1980).

    PubMed  CAS  Google Scholar 

  26. J. L. Nadler, J. S. Velasco and R. Horton. Cigarette smoking inhibits prostacyclin formation. Lancet 1:248 (1983).

    Google Scholar 

  27. G. A. FitzGerald, B. Smith, A. K. Pedersen and A. R. Brash. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N. Engl. J. Med. 310:1065 (1984).

    Article  PubMed  CAS  Google Scholar 

  28. I. A. G. Reilly, L. Roy and G. A. FitzGerald. Thromboxane biosynthesis is increased in systemic sclerosis with Raynaud’s phenomenon. Br.Med.J. 292:1087 (1986).

    Article  Google Scholar 

  29. J. J. Murray, J. Nowak, J. A. Oates and G. A. FitzGerald. Biosynthesis of thromboxane A2 and prostacyclin during chronic smoking and withdrawal in man. Clin. Res. 33:521A (1985).

    Google Scholar 

  30. I. A. G. Reilly and G. A. FitzGerald. Eicosanoid biosynthesis and platelet function with advancing age. Thrombosis Res. 41:545 (1986).

    Article  CAS  Google Scholar 

  31. G. A. Kyerematen, M. D. Damiano, B. H. Dvorchik and E. S. Vesell. Smoking-induced changes in nicotine disposition: Application of a new HPLC assay for nicotine and its metabolites. Clin. Pharmacol. Ther. 32:769 (1982).

    Article  PubMed  CAS  Google Scholar 

  32. J.J. Murray, J. Nowak, J. A. Oates and G. A. FitzGerald. Platelet function during chronic smoking and withdrawal. Clin. Res. 33:350A (1985).

    Google Scholar 

  33. J. Nowak, J. J. Murray, J. A. Oates and G. A. Fitzgerald. Biochemical evidence of a chronic abnormality in platelet and vascular function in apparently healthy chronic cigarette smokers. Circulation 76:6 (1987).

    Article  PubMed  CAS  Google Scholar 

  34. S. Fischer, C. Bernutz, H. Meier and P. C. Weber. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. Biochim. Biophys. Acta 876:194 (1986).

    PubMed  CAS  Google Scholar 

  35. R. Lassila, H. W. Seyberth, A. Haspanen, H. W. Schweer, M. Koskenvuo and K. E. Laustiola. Vasoactive and atherogenic effects of cigarette smoking- a study of monozygotic twins discordant for smoking. Br. Med. J. 297:955 (1988).

    Article  CAS  Google Scholar 

  36. Å. Wennmalm. Smoking induced alterations in thromboxane biosynthesis: a population study. Presented at the Winter Prostaglandin Conference. Keystone, CO (1988).

    Google Scholar 

  37. S. E. Barrow, P. S. Ward. M. A. Sleightholm, J. M. Ritter and C. T. Dollery. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in urine. Biochim. Biophys. Acta 993:121 (1989).

    Article  PubMed  CAS  Google Scholar 

  38. G. A. FitzGerald, J. A. Oates, J. Hawiger, R. L. Maas, L. J. Roberts II, J. A. Lawson and A. R. Brash. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during administration of aspirin in man. J. Clin. Invest. 71:676 (1983).

    Article  PubMed  CAS  Google Scholar 

  39. A. K. Pedersen, J. Nowak and G. A. FitzGerald. Slow administration of low dose aspirin:Enhanced inhibition of platelet cyclooxygenase. Circulation 72:772A (1985).

    Article  Google Scholar 

  40. G. A. FitzGerald, A. R. Brash, I. A. Blair and J. Lawson. Analysis of urinary metabolites of thromboxane and prostacyclin by negative ion-chemical ionization gas chromatography-mass spectrometry. Adv. Prostglandin Thromboxane Res. 15:87 (1985).

    CAS  Google Scholar 

  41. P. Hill and E. L. Wyner. Smoking and cardiovascular disease- effect of nicotine on the serum epinephrine and corticoids. Am. Heart J. 87:491 (1974).

    Article  PubMed  CAS  Google Scholar 

  42. R. M. Pittilo, J. M. Clarke, D. Harris, I. J. Mackie, P. M. Rowles, S. J. Machin and N. Woolf. Cigarette smoking and platelet adhesion. Br. J. Haematol. 58:627 (1984).

    Article  PubMed  CAS  Google Scholar 

  43. P. E. Cryer, M. W. Haymond, J. V. Santiago and S. D. Shah. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 295:573 (1976).

    Article  PubMed  CAS  Google Scholar 

  44. P. H. Levine. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 48:619 (1973).

    PubMed  CAS  Google Scholar 

  45. J. J. Belch, B. M. McArdle, P. Burns, G. D. Lowe and C. D. Forbes. The effects of acute smoking on platelet behaviour, fibrinolysis haemarheology in habitual smokers. Thromb. Haemostasis 51:6 (1984).

    CAS  Google Scholar 

  46. T. Gordon, W. B. Kannel, D. McGee and T. R. Dawber. Death and coronary attacks in men giving up smoking. A report of the Framingham study. Lancet ii:1345 (1974).

    Article  Google Scholar 

  47. R. Doll and A. B. Hill. Mortality in relation to smoking: Ten years’ observation of British doctors. Br. Med. J. 1:1406 (1964).

    Google Scholar 

  48. L. Wilhelmsen. Coronary artery disease: Epidemiology of smoking and intervention studies of smoking. Am. Heart J. 115:242 (1988).

    Article  PubMed  CAS  Google Scholar 

  49. L. Rosenberg, D. W. Kaufman, S. P. Helmrich and S. Shapiro. Risk of myocardial infarction after quitting smoking in men under 55 years of age. N. Engl. J. Med. 313:1511 (1985).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology Departments of Medicine and Pharmacology, Vanderbilt Medical Center, Nashville, TN, 37232, USA

    John J. Murray, Jacek Nowak, John A. Oates & Garret A. FitzGerald

Authors
  1. John J. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacek Nowak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John A. Oates
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Garret A. FitzGerald
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tobacco and Health Research Institute, University of Kentucky, Lexington, Kentucky, USA

    John N. Diana

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Murray, J.J., Nowak, J., Oates, J.A., FitzGerald, G.A. (1990). Platelet — Vessel Wall Interactions in Individuals who Smoke Cigarettes. In: Diana, J.N. (eds) Tobacco Smoking and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 273. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5829-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5829-9_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5831-2

  • Online ISBN: 978-1-4684-5829-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation